Literature DB >> 15355487

IgA antibodies against gliadin and gluten in multiple sclerosis.

K-L Reichelt1, D Jensen.   

Abstract

BACKGROUND: Multiple changes in antibodies against various antigens are found in multiple sclerosis (MS).
OBJECTIVE: We wanted to measure immunoglobulin A (IgA) antibodies to some common food antigens in MS and also IgG against gliadin and gluten.
METHODS: The IgA antibodies were measured in serum against gluten, gliadin, lactoglobulin, lactalbumin, casein and ovalbumin in patients with MS and controls using ELISA technique. IgG was likewise measured for gluten and gliadin.
RESULTS: Highly significant increases compared with controls were found for IgA and IgG antibodies against gliadin and gluten. IgA antibodies against casein were significantly increased. Anti-endomycium and anti-transglutaminase antibodies were negative.
CONCLUSIONS: The data presented indicate that there may be a possible moderately increased uptake of some specific proteins from the gut in MS compared with controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355487     DOI: 10.1111/j.1600-0404.2004.00303.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

Review 1.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

Review 2.  The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.

Authors:  Leah J Mische; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2018-03-17       Impact factor: 3.598

Review 3.  Nutrition facts in multiple sclerosis.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  ASN Neuro       Date:  2015-02-18       Impact factor: 4.146

4.  Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.

Authors:  Tamas Tornai; Eszter Palyu; Zsuzsanna Vitalis; Istvan Tornai; David Tornai; Peter Antal-Szalmas; Gary L Norman; Zakera Shums; Gabor Veres; Antal Dezsofi; Gabriella Par; Alajos Par; Peter Orosz; Ferenc Szalay; Peter Laszlo Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

Review 5.  Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.

Authors:  Hammad Ullah; Olga Tovchiga; Maria Daglia; Haroon Khan
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

Review 6.  Interrelation of Diet, Gut Microbiome, and Autoantibody Production.

Authors:  Ioanna Petta; Judith Fraussen; Veerle Somers; Markus Kleinewietfeld
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

Review 7.  Undigested Food and Gut Microbiota May Cooperate in the Pathogenesis of Neuroinflammatory Diseases: A Matter of Barriers and a Proposal on the Origin of Organ Specificity.

Authors:  Paolo Riccio; Rocco Rossano
Journal:  Nutrients       Date:  2019-11-09       Impact factor: 5.717

Review 8.  Current Evidence on the Efficacy of Gluten-Free Diets in Multiple Sclerosis, Psoriasis, Type 1 Diabetes and Autoimmune Thyroid Diseases.

Authors:  Moschoula Passali; Knud Josefsen; Jette Lautrup Frederiksen; Julie Christine Antvorskov
Journal:  Nutrients       Date:  2020-08-01       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.